The Global Pharmaceutical Industry: Swallowing a Bitter Pill The case describes the evolution of the pharmaceutical industry and its strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical needs‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D productivity‚ led
Premium Medicine Pharmacology Industry
Motivating high performance in pharmaceutical sales teams is a growing issue in the pharmaceutical industry. The challenges facing the pharmaceutical industry in motivating sales teams are compounded by a variety of factors that many other industries do not face including: government regulation of sales practices‚ non-direct tracking of sales results‚ and the impact of managed care on sales performance. By impacting a few key team process and compensation elements pharmaceutical companies can have a significant
Premium Pharmacology Pharmaceutical drug Pharmacy
Environmental Factors Angela Mackey MKT 421 January 4‚ 2011 Harry Caldwell Environmental Factors Marketing in the world today is affected by so many factors in the environment. The factors include political and legal issues‚ which are the most important. Some other environmental factors that have a major effect on the marketing world are social‚ cultural economics‚ technological‚ and competitive. These factors surround the basis of the decisions made within marketing. Most organizations
Premium Marketing International trade Marketing plan
the factors affecting growth and development ProText Knowledge Services Global Pharmaceutical Market: Overview 1. Indust ry Overview The pharmaceutical industry of the world develops and markets medicines prescribed for patients by medical practitioners. The U.S.‚ U.K and European pharmaceutical companies are the major ones of the industry. The total number of major pharmaceutical companies (annual revenues USD 1‚000 million and above) worldwide The global pharmaceutical industry is estimated
Premium Pharmaceutical industry Generic drug Drug development
MICRO ENVIRONMENTALFORCES | EVENTS | IMPACTOPPORTUNITIES/THREATS | COMPETITORS | * YEOS * POKKA | -VE IMPACT * Holds high percentage of market share * Both YEOS and POKKA are the leading brand in the Asian Specialty drinks category. They both have their own loyal group of consumer. In addition to that‚ they also have similar range of product‚ pricing‚ placing of product as F&N Seasons .Thus‚ they are viewed as the strongest competitor to F&N Seasons * Products are similar
Premium Marketing Competition Price
Application of statistics in Pharmaceutical industry * * * Bookmark Although the advancement of medicine has prolonged and improved the life of many people over the years‚ it is important to remember that it is not an exact science. While some treatments do seem to offer a complete ’cure’ for any particular ailment universally‚ the vast majority of medicinal treatments do not. As such‚ it is important that statistics are used in medicine in order to justify the development and subsequent
Premium Obesity Metabolic syndrome
developed economies of the world. It is important to take a holistic view of the prevailing policy framework covering generic drugs globally‚ making it possible to analyze the effects of these policies on the generic pharmaceutical industry. The first pertinent area of global pharmaceutical policy is funding of research in life sciences. This pertains primarily to reference drugs rather than generic drugs. Globally‚ there is no overarching framework for the same. This is primarily done only in the
Premium Health care Medicine Health
Institutional Area‚ Behind the Grand Hotel‚ Vasant Kunj‚ New Delhi – 110070 Tel.: 2612409090 / 91; Fax: 26124092 E-mail: administration@srisim.org; Website: www.srisim.org DEVELOPMENT DAY PROJECT REPORT STRATEGIC ALLIANCE IN INDIAN PHARMACEUTICAL INDUSTRY Submitted by: | Name: Jagriti Singh (20090123) Amardeep Tomar(20090106) Shilpa Jaiswal(20090155) Anil Chauhan(20090108) | Batch: | 2009 – 2011. | MANAGING THROUGH WISDOM INTRODUCTION The
Premium Pharmaceutical industry Pharmacology Drug discovery
Global Business Environment Issues: Economic and Socio-economic Factors Table of Contents ACKNOWLEDGEMENT 2 EXECUTIVE SUMMARY 4 GLOBAL BUSINESS ENVIRONMENT FORCES 5 ECONOMIC AND SOCIO-ECONOMIC FORCES 7 LEVELS OF ECONOMIC DEVELOPMENT 9 ECONOMIC DIMENSIONS 13 SOCIO-ECONOMIC DIMENSIONS 22 CONCLUSION 24 BIBLIOGRAPHY 25 EXECUTIVE SUMMARY This report analyzes the practical implication and analysis of some of the important aspects of Organizational
Premium Economics Developed country Gross domestic product
Summer Internship Project In Depth Fundamental Analysis of Pharmaceutical Industry Submitted in partial fulfillment of PGDM program 2009-11 [pic] Submitted by Vikas Khandelwal 17/058 Company Guide Faculty Guide Name: Mr. Ritesh Purohit Name: Ms. Ruchi Paliwal Assistant Vice President Globe Capital Market Ltd. Apeejay School of Management New Delhi July 2010 ACKNOWLEDGEMENT This project would have been difficult to complete without the invaluable contributions
Premium Stock market Fundamental analysis Technical analysis